Hybrid convergent procedure for the treatment of persistent and long-standing persistent atrial fibrillation

Abstract

Recent advances have been made in AF treatment Including the role of early rhythm control and landmark clinical trials using ablation therapy. However Some treatment gaps remain including the creation of durable lesions outside the pulmonary veins and effective treatment of longstanding persistent AF. A novel epicardial-endocardial ablation approach - the hybrid convergent procedure - was developed to combine surgical and catheter ablation techniques into a collaborative multidisciplinary approach to managing AF. In this review the authors discuss recently published data on hybrid convergent ablation including results of the CONVERGE clinical trial in the context of current challenges to treatment of persistent and long-standing persistent AF. The review also aims to provide perspective on outstanding questions and future directions in this area.